Company Overview
CORCEPT THERAPEUTICS INC
CORTRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
761M
2025 FY
Net Income
100M
2025 FY
Shares Outstanding
104M
2025 FY
EPS
0.95USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1088856
Exchange
Nasdaq
Location
US